MATTHEW HAROLD KATZ to Protein Kinase Inhibitors
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Protein Kinase Inhibitors.
Connection Strength
0.013
-
The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma. Urology. 2017 10; 108:114-121.
Score: 0.013
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.